1 signal · h1b_lca
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Moderate risk indicators present across data sources.
Signals suggest Alto Pharmacy is engaging in targeted skilled hiring via H-1B/E-3 LCA filings in FY2026 Q2.
Patterns indicate active recruitment of specialized labor, as evidenced by a single certified H-1B/E-3 LCA filing in FY2026 Q2 for one position with a median offered salary of $214,200/yr. Confidence in broader hiring trends remains low due to limited review coverage and sparse data.
What this means
Limited signals collected so far — this score may shift significantly as more data arrives.
AI-generated from public signals — may be incomplete. Based on 1 recent signal.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Modern pharmacy with home delivery.
Based on 1 signal across 1 source · snapshot 9 Jul 2026
Limited — treat this score as early-stage; more data needed.
Limited coverage — score may shift as signals arrive.
Based on 1 signal across 1 source
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.